Abstract
Low and variable efficiency is a major problem in targeted gene alteration, which is used as a primary tool in gene therapy and animal model studies. We tested several types of constructs alone, or in combination with other factors, to introduce a point mutation into the αB-crystallin gene in one-celled mouse embryos. We found that co-injection of ssDNA along with antibodies against Ku70/86, or supplementing the system with hRad51/hRad54, increases efficiency of targeted mutagenesis. These findings suggest that proteins in the homologous recombination DNA repair pathway contribute, and that proteins involved in the alternative nonhomologous end-joining pathway inhibit, ssDNA-mediated targeted mutagenesis. This is the first successful demonstration of targeted mutation in early mouse embryos. This novel methodology of supplying protein factors to stimulate gene modification in the nucleus has not been previously reported.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Tagalakis AD, Owen JS, Simons JP . Lack of RNA–DNA oligonucleotide (Chimeraplast) mutagenic activity in mouse embryos. Mol Reprod Dev 2005; 71: 140–144.
Pierce EL, Liu Q, Igoucheva O, Omarrudin R, Ma H, Diamond SL et al. Oligonucleotide-directed single-base DNA alterations in mouse embryonic stem cells. Gene Therapy 2003; 1: 24–33.
Murphy BR, Moayedpardazi HS, Gewirtz AM, Diamond SL, Pierce EA . Delivery and mechanistic considerations for the production of knock-in mice by single-stranded oligonucleotide gene targeting. Gene Therapy 2007; 14: 304–315.
Fiorenza MT, Bevilacqua A, Bevilacqua S, Mangia F . Growing dictyate oocytes, but not early preimplantation embryos, of the mouse display high levels of DNA homologous recombination by single-strand annealing and lack DNA nonhomologous end joining. Dev Biol 2001; 233: 214–224.
Vasquez KM, Narayanan L, Glazer PM . Specific mutations induced by triplex-forming oligonucleotides in mice. Science 2000; 290: 530–533.
Luo ZM, Macris MA, Faruqi AF, Glazer PM . High-frequency intrachromosomal gene conversion induced by triplex-forming oligonucleotides microinjected into mouse cells. Proc Natl Acad Sci USA 2000; 97: 9003–9008.
Cole-Strauss A, Yoon K, Xiang Y, Byrne BC, Rice MC, Gryn J et al. Correction of the mutation responsible for sickle cell anemia by an RNA-DNA oligonucleotide. Science 1996; 273: 626–634.
Yoon K, Cole-Strauss A, Kmiec EB . Targeted gene correction of episomal DNA in mammalian cells mediated by a chimeric RNA/DNA oligonucleotide. Proc Natl Acad Sci USA 1996; 93: 2071–2076.
Alexeev V, Igoucheva O, Domashenko A, Cotsarelis G, Yoon K . Localized in vivo genotypic and phenotypic correction of the albino mutation in skin by RNA-DNA oligonucleotide. Nat Biotechnol 2000; 18: 43–47.
Alexeev V, Yoon K . Stable and inheritable changes in genotype and phenotype of albino melanocytes induced by an RNA-DNA oligonucleotide. Nat Biotechnol 1998; 16: 1343–1346.
Rogers FA, Vasquez KM, Egholm M, Glazer PM . Site-directed recombination via bifunctional PNA-DNA conjugates. Proc Natl Acad Sci USA 2002; 99: 16695–16700.
Thorpe PH, Stevenson BJ, Porteous DJ . Functional correction of episomal mutations with short DNA fragments and RNA–DNA oligonucleotides. J Gene Med 2002; 4: 195–205.
Igoucheva O, Alexeev V, Yoon K . Targeted gene correction by small single-stranded oligonucleotides in mammalian cells. Gene Therapy 2001; 8: 391–399.
Liu L, Rice MC, Kmiec EB . In vivo gene repair of point and frameshift mutations directed by chimeric RNA/DNA oligonucleotides and modified single-stranded oligonucleotides. Nucleic Acids Res 2001; 29: 4238–4250.
Ellis HM, Yu D, DiTizio T, Court DL . High efficiency mutagenesis, repair, and engineering of chromosomal DNA using single-stranded oligonucleotides. Nucleic Acids Res 2001; 98: 6742–6746.
Seidman MM . Oligonucleotide mediated gene targeting in mammalian cells. Curr Pharm Biotechnol 2004; 5: 421–430.
Taubes G . The strange case of chimeraplasty. Science 2002; 298: 2116–2120.
Albuquerque-Silva J, Vassart G, Lavinha J, Abramowicz MJ . Chimeraplasty validation. Nat Biotechnol 2001; 19: 1011.
van der Steege G, Schuilenga-Hut PHL, Buys CHCM, Scheffer H, Pas HH, Jonkman MF . Persistent failures in gene repair. Nat Biotechnol 2001; 19: 305–306.
Cole-Strauss A, Gamper H, Holloman WK, Munoz M, Cheng N, Kmiec EB . Targeted gene repair directed by the chimeric RNA/DNA oligonucleotide in a mammalian cell-free extract. Nucleic Acids Res 1999; 27: 1323–1330.
Liu L, Cheng S, van Brabant AJ, Kmiec EB . Rad51p and Rad54p, but not Rad52p, elevate gene repair in Saccharomyces cerevisiae directed by modified single-stranded oligonucleotide vectors. Nucleic Acids Res 2002; 30: 2742–2750.
Wang Z, Zhou ZJ, Liu DP, Huang JD . Single-stranded oligonucleotide-mediated gene repair in mammalian cells has a mechanism distinct from homologous recombination repair. Biochem Biophys Res Commun 2006; 350: 568–573.
Igoucheva O, Alexeev V, Scharer O, Yoon K . Involvement of ERCC1/XPF and XPG in oligodeoxynucleotide-directed gene modification. Oligonucleotides 2006; 16: 94–104.
Jeggo PA . DNA breakage and repair. Adv Genet 1998; 38: 185–218.
Morozov VE, Falzon M, Anderson CW, Kuff EL . DNA-dependent protein kinase is activated by nicks and larger single-stranded gaps. J Biol Chem 1994; 269: 16684–16688.
Sigurdsson S, Van Komen S, Petukhova G, Sung P . Homologous DNA pairing by human recombination factors Rad51 and Rad54. J Biol Chem 2002; 277: 42790–42794.
Kanungo J, Empson RM, Rasmussen H . Microinjection of an antibody to the Ku protein arrests development in sea urchin embryos. Biol Bull 1999; 197: 341–347.
Acknowledgements
This research was supported by the Intramural Research Program of the NEI, NIH, DHHS. We thank Dr Patrick Sung, Yale University School of Medicine for kindly providing us with recombinant human Rad51, Rad51KR and Rad54 proteins. We also thank Dr Joram Piatigorsky from NEI, NIH, for helpful discussions, critical reading of the manuscript and support of this project.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on Gene Therapy website (http://www.nature.com/gt)
Supplementary information
Rights and permissions
About this article
Cite this article
Morozov, V., Wawrousek, E. Single-strand DNA-mediated targeted mutagenesis of genomic DNA in early mouse embryos is stimulated by Rad51/54 and by Ku70/86 inhibition. Gene Ther 15, 468–472 (2008). https://doi.org/10.1038/sj.gt.3303088
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3303088
Keywords
This article is cited by
-
Combinatorial gene editing in mammalian cells using ssODNs and TALENs
Scientific Reports (2014)
-
DNA Damage Response Pathway and Replication Fork Stress During Oligonucleotide Directed Gene Editing
Molecular Therapy - Nucleic Acids (2012)
-
Progress and prospects: oligonucleotide-directed gene modification in mouse embryonic stem cells: a route to therapeutic application
Gene Therapy (2011)
-
Genetic correction of splice site mutation in purified and enriched myoblasts isolated from mdx5cv mice
BMC Molecular Biology (2009)